Skip to main content
Caplight Logo









Evoluno

Evoluno

Private
BrusselsHealthcare & Life Scienceshttps://evoluno.com/

Last Round

Seed

Feb 1, 2022

Total Funding Raised

$680,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Evoluno operates in Healthcare & Life Sciences and is based in Brussels. Its latest recorded funding round was a Seed round in February 2022.

Evoluno is a healthcare IT company that provides a digital mental health platform for organizations to monitor employee well-being, offer self-care resources, and connect users with licensed therapists.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Telemedicine, HR, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Evoluno Comparables

Compare Evoluno with similar companies based on industry and business-model similarity.

Evoluno comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kyan Health
84%
Spill
83%
moka.care
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Evoluno Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 1, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Evoluno Investors

Notable investors and investment history

Evoluno investors
InvestorRounds
Digital AttraxionSeed
finance&invest.brusselsSeed
NivelinvestSeed
BeAngelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 46% MoM.

  • Jul 26, 2026

    Monthly visitors increased 166% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Evoluno Filings

Explore SEC and related filing metadata, where available.

Evoluno filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Evoluno's valuation, stock price, and market status.

Is Evoluno a public or private company?

Evoluno is a private company.

What is the current stock price of Evoluno?

Evoluno is a private company, so its shares have no public market price. Caplight tracks Evoluno's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Evoluno worth (valuation)?

Valuation information for Evoluno is not publicly available.

Can I buy Evoluno stock?

Evoluno shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Evoluno's last funding round?

Evoluno's most recent funding round was Seed on February 1, 2022.

Who are the main investors in Evoluno?

Key investors in Evoluno include Digital Attraxion, finance&invest.brussels, Nivelinvest, BeAngels.

Will Evoluno IPO soon?

No public IPO plans have been announced for Evoluno.

How can I track Evoluno secondary market activity?

Caplight tracks bids, offers, and trades in Evoluno's shares on secondary markets.

Firmographic Details

HeadquartersBrussels
Employee Range9
Year Founded2020
Last FundingFeb 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?